Abstract: Abstract Considerable progress has been made over the past few years in the development and regulatory adoption of in vitro and in chemico methods addressing key events of the skin sensitisation pathway. When used in isolation these methods are not able to generate information on skin sensitisation potential and potency comparable to that of the standard in vivo tests and for this reason they are proposed to be used in a weight-of-evidence assessment context within integrated approaches to testing and assessment. The integration of non-animal d...
(read more)
Topics: 
Risk analysis (engineering)
Computational biology